G. Saydam Et Al. , "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia," 55th Annual Meeting of the American-Society-of-Hematology , vol.122, Louisiana, United States Of America, 2013
Saydam, G. Et Al. 2013. Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia. 55th Annual Meeting of the American-Society-of-Hematology , (Louisiana, United States Of America).
Saydam, G., Haznedaroglu, I. C., Kaynar, L., YAVUZ, A. S., ALI, R., Guvenc, B., ... AKAY, O. M.(2013). Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia . 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America
Saydam, Guray Et Al. "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia," 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 2013
Saydam, Guray Et Al. "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America, 2013
Saydam, G. Et Al. (2013) . "Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America.
@conferencepaper{conferencepaper, author={Guray Saydam Et Al. }, title={Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia}, congress name={55th Annual Meeting of the American-Society-of-Hematology}, city={Louisiana}, country={United States Of America}, year={2013}}